Author:
N. Sriram ,N. Elavarasan ,S. Kameshwaran ,S. Deepanchakkaravarthi ,DS. Asok Kumar
Abstract
This review synthesizes current knowledge and preparedness strategies regarding Disease X, a placeholder for an unforeseen global health threat posed by an unknown pathogenic entity. Drawing from an exhaustive analysis of literature from 1990 to 2023, the review illuminates multifaceted preparedness and response frameworks worldwide for emergent infectious diseases. The analysis discerns notable disparities in readiness, with developed nations showcasing advanced preparedness models characterized by vigilant surveillance, resilient health systems, skilled workforce, community engagement, and collaborative international stances. However, an evident global preparedness gap is underscored, necessitating intensified, cohesive international efforts to preemptively address and counteract Disease X effectively. The review culminates in a call for bolstered global solidarity, emphasizing equity, collaboration, and adaptability as cornerstone principles for fortifying global defenses against the imminent and unpredictable threat of Disease X.
Reference11 articles.
1. Prioritizing diseases for research and development in emergency contexts. World Health Organization website [cited May 30, 2021]. Available from: https://www.who.int/activities/prioritizing-diseases-for-research-and-development-in-emergency-contexts.
2. Disease X: Science fiction or a very real and frightening threat? The Telegraph [website] [cited Jun 1, 2021]. Available from: https://www.telegraph.co.uk/global-health/science-and-disease/must-work-together-prevent-disease-x/.
3. Honigsbaum M. Disease X and other unknowns. Lancet. 2019;393(10180):1496-7. doi: 10.1016/S0140-6736(19)30803-7, PMID 30983581.
4. Jiang S, Shi ZL. The first Disease X is caused by a highly transmissible acute respiratory syndrome coronavirus. Virol Sin. 2020;35(3):263-5. doi: 10.1007/s12250-020-00206-5, PMID 32060789.
5. Barrett ADT. Developing Zika vaccines: the lessons for Disease X. Genome Med. 2018;10(1):47. doi: 10.1186/s13073-018-0561-2, PMID 29945653.